Update on Dialco Deal with Infomed?Eazeetrade1 - Jan 16 2023 - "Response from Spectral wrt to Dialco" below:
As such, Spectral was not required to file a material change report in respect of the Dialco Restructuring, nor was Spectral required to file or publicly disclose the transaction agreements relating to the Dialco Restructuring (the “Transaction Agreements”) on SEDAR. As such, given that Spectral is not required by law to provide additional disclosure regarding the Dialco Restructuring, the provisions of the Transaction Agreements prevent further disclosure of the confidential terms of the Transaction Agreements without the approval of Infomed, which is not forth coming. However, some further details of the Dialco Restructuring will be contained in our annual financial statements and accompanying MD&A for the period ended December 31, 2022, which we expect to publish at the end of March 2023.
If what was said to Eazeetrade1 was true we should know the "not material" secrets soon surrounding the loss of equity in Dialco to Infomed. They "will be contained" in the annual documents.